Officinalisinin I exhibits significant anti-inflammatory and antioxidant properties, making it valuable in pharmaceutical and cosmetic formulations. It is used in the development of topical treatments for skin conditions such as dermatitis, eczema, and psoriasis due to its ability to reduce oxidative stress and modulate inflammatory pathways. Additionally, it has shown potential in supporting liver health by enhancing detoxification processes and protecting hepatocytes from toxin-induced damage. Its bioactivity also contributes to research in metabolic disorder management, particularly in regulating glucose and lipid metabolism. Due to its natural origin and low toxicity profile, it is increasingly explored in nutraceuticals and functional foods aimed at promoting overall wellness.